Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
Sale of product	$ 1,948,856	$ 1,672,789
Cost of product	1,144,428	1,093,269
Gross profit	804,428	579,520
Operating costs and expenses:
Salaries and contract labor	387,358	452,460
General, administrative and consulting	507,222	481,522
Research and development	81,947	232,819
Total operating expenses	976,527	1,166,801
Operating loss	(172,099)	(587,281)
Other income (expense):
Other income (expense)	5,283	4,165
Equity in net income of affiliate	21,580	2,746
Interest income	295	388
Interest expense	(309,669)	(100,118)
Total other income (expense)	(282,511)	(92,819)
Net loss	(454,610)	(680,100)
Loss attributable to non-controlling interest	2,405	11,208
Net loss attributable to International Isotopes Inc.	$ (452,205)	$ (668,892)
Net loss per common share - basic and diluted	$ 0.00	$ 0.00
Weighted average common shares outstanding - basic and diluted	369,150,813	360,420,968